Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Among men with nonmetastatic, castration-resistant prostate cancer with a rapidly rising PSA level, enzalutamide treatment led to a clinically meaningful and significant 71% low...